As a result, five MTGs (RPS6KA5, RORA, SH3BP5, NUPR1 and CD40LG) were found to be significantly correlated with a better OS of NSCLC patients (Figure 3B). The gene discussed is RPS6KA5; the disease is non-small cell lung carcinoma.